Testing HB0043 for moderate to severe acne
Part of Skin clinical trials.
This trial tests a new medicine, HB0043, to see if it helps adults with moderate to severe facial acne. You cannot use other acne treatments during the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate to severe acne on your face.
- You are 18 years old or older.
- You agree to not use other acne products during the study.
- You are willing to use birth control if you could become pregnant (for the study and 3 months after).
- You do not have other serious skin conditions, infections, or health problems listed in the exclusions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination hormonal pill (a progestogen and low-dose estrogen) to treat moderate acne in women. It may be an option if you have not had success with other acne treatments.
This study tests whether balancing the bacteria on your skin can help treat mild to moderate acne. Researchers will take facial photos and follow your progress to see if this new approach works.
This trial tests three different gel treatments for mild to moderate acne on the face. One gel contains clindamycin and retinoid, another adds dexamethasone, and the third uses a special stem-cell secretion. All are applied to the face for 8 weeks.
This trial tests if a new cleanser and cream combination can safely treat mild to moderate acne. It may help people who have not used other acne treatments recently.
This trial tests a cream called KR230109 for mild to moderate facial acne. It aims to see if the cream is safe and works well. You may qualify if you are 18 to 40 and have at least 10 pimples and 20 blackheads or whiteheads on your face, but no deep cysts.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.